 | • レポートコード：QYR9ST01968 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のエリスロポエチン（EPO）市場について調査・分析し、以下の構成でお届け致します。エリスロポエチン（EPO）の種類別には、エポエチン-アルファ、ダルベポエチン-アルファ、エポエチン-ベータ、その他に、用途別には、貧血、腎臓障害、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別エリスロポエチン（EPO）売上データ ・地域別エリスロポエチン（EPO）市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別エリスロポエチン（EPO）市場規模：エポエチン-アルファ、ダルベポエチン-アルファ、エポエチン-ベータ、その他 ・用途別エリスロポエチン（EPO）市場規模：貧血、腎臓障害、その他 ・主要メーカーの企業情報：Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences ・エリスロポエチン（EPO）の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of Erythropoietin (EPO) Drugs market.According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.
The global Erythropoietin (EPO) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Erythropoietin (EPO) market based on company, product type, end user and key regions.
This report studies the global market size of Erythropoietin (EPO) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Erythropoietin (EPO) in these regions.
This research report categorizes the global Erythropoietin (EPO) market by top players/brands, region, type and end user. This report also studies the global Erythropoietin (EPO) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Market size by Product
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Market size by End User
Anemia
Kidney Disorders
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Erythropoietin (EPO) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Erythropoietin (EPO) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Erythropoietin (EPO) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Erythropoietin (EPO) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Erythropoietin (EPO) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Erythropoietin (EPO) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Erythropoietin (EPO) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Erythropoietin (EPO) Market Size Growth Rate by Product
1.4.2 Epoetin-alfa
1.4.3 Darbepoetin-alfa
1.4.4 Epoetin-beta
1.4.5 Others
1.5 Market by End User
1.5.1 Global Erythropoietin (EPO) Market Size Growth Rate by End User
1.5.2 Anemia
1.5.3 Kidney Disorders
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Erythropoietin (EPO) Market Size
2.1.1 Global Erythropoietin (EPO) Revenue 2014-2025
2.1.2 Global Erythropoietin (EPO) Sales 2014-2025
2.2 Erythropoietin (EPO) Growth Rate by Regions
2.2.1 Global Erythropoietin (EPO) Sales by Regions
2.2.2 Global Erythropoietin (EPO) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Erythropoietin (EPO) Sales by Manufacturers
3.1.1 Erythropoietin (EPO) Sales by Manufacturers
3.1.2 Erythropoietin (EPO) Sales Market Share by Manufacturers
3.1.3 Global Erythropoietin (EPO) Market Concentration Ratio (CR5 and HHI)
3.2 Erythropoietin (EPO) Revenue by Manufacturers
3.2.1 Erythropoietin (EPO) Revenue by Manufacturers (2014-2019)
3.2.2 Erythropoietin (EPO) Revenue Share by Manufacturers (2014-2019)
3.3 Erythropoietin (EPO) Price by Manufacturers
3.4 Erythropoietin (EPO) Manufacturing Base Distribution, Product Types
3.4.1 Erythropoietin (EPO) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Erythropoietin (EPO) Product Type
3.4.3 Date of International Manufacturers Enter into Erythropoietin (EPO) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Erythropoietin (EPO) Sales by Product
4.2 Global Erythropoietin (EPO) Revenue by Product
4.3 Erythropoietin (EPO) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Erythropoietin (EPO) Breakdown Data by End User
6 North America
6.1 North America Erythropoietin (EPO) by Countries
6.1.1 North America Erythropoietin (EPO) Sales by Countries
6.1.2 North America Erythropoietin (EPO) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Erythropoietin (EPO) by Product
6.3 North America Erythropoietin (EPO) by End User
7 Europe
7.1 Europe Erythropoietin (EPO) by Countries
7.1.1 Europe Erythropoietin (EPO) Sales by Countries
7.1.2 Europe Erythropoietin (EPO) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Erythropoietin (EPO) by Product
7.3 Europe Erythropoietin (EPO) by End User
8 Asia Pacific
8.1 Asia Pacific Erythropoietin (EPO) by Countries
8.1.1 Asia Pacific Erythropoietin (EPO) Sales by Countries
8.1.2 Asia Pacific Erythropoietin (EPO) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Erythropoietin (EPO) by Product
8.3 Asia Pacific Erythropoietin (EPO) by End User
9 Central & South America
9.1 Central & South America Erythropoietin (EPO) by Countries
9.1.1 Central & South America Erythropoietin (EPO) Sales by Countries
9.1.2 Central & South America Erythropoietin (EPO) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Erythropoietin (EPO) by Product
9.3 Central & South America Erythropoietin (EPO) by End User
10 Middle East and Africa
10.1 Middle East and Africa Erythropoietin (EPO) by Countries
10.1.1 Middle East and Africa Erythropoietin (EPO) Sales by Countries
10.1.2 Middle East and Africa Erythropoietin (EPO) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Erythropoietin (EPO) by Product
10.3 Middle East and Africa Erythropoietin (EPO) by End User
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Erythropoietin (EPO) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Erythropoietin (EPO) Products Offered
11.1.5 Amgen Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Company Business Overview
11.2.3 Johnson & Johnson Erythropoietin (EPO) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Johnson & Johnson Erythropoietin (EPO) Products Offered
11.2.5 Johnson & Johnson Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche Erythropoietin (EPO) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roche Erythropoietin (EPO) Products Offered
11.3.5 Roche Recent Development
11.4 Galenica
11.4.1 Galenica Company Details
11.4.2 Company Business Overview
11.4.3 Galenica Erythropoietin (EPO) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Galenica Erythropoietin (EPO) Products Offered
11.4.5 Galenica Recent Development
11.5 Emcure
11.5.1 Emcure Company Details
11.5.2 Company Business Overview
11.5.3 Emcure Erythropoietin (EPO) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Emcure Erythropoietin (EPO) Products Offered
11.5.5 Emcure Recent Development
11.6 Kyowa Hakko Kirin
11.6.1 Kyowa Hakko Kirin Company Details
11.6.2 Company Business Overview
11.6.3 Kyowa Hakko Kirin Erythropoietin (EPO) Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Kyowa Hakko Kirin Erythropoietin (EPO) Products Offered
11.6.5 Kyowa Hakko Kirin Recent Development
11.7 3SBio
11.7.1 3SBio Company Details
11.7.2 Company Business Overview
11.7.3 3SBio Erythropoietin (EPO) Sales, Revenue and Gross Margin (2014-2019)
11.7.4 3SBio Erythropoietin (EPO) Products Offered
11.7.5 3SBio Recent Development
11.8 Biocon
11.8.1 Biocon Company Details
11.8.2 Company Business Overview
11.8.3 Biocon Erythropoietin (EPO) Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Biocon Erythropoietin (EPO) Products Offered
11.8.5 Biocon Recent Development
11.9 LG Life Sciences
11.9.1 LG Life Sciences Company Details
11.9.2 Company Business Overview
11.9.3 LG Life Sciences Erythropoietin (EPO) Sales, Revenue and Gross Margin (2014-2019)
11.9.4 LG Life Sciences Erythropoietin (EPO) Products Offered
11.9.5 LG Life Sciences Recent Development
12 Future Forecast
12.1 Erythropoietin (EPO) Market Forecast by Regions
12.1.1 Global Erythropoietin (EPO) Sales Forecast by Regions 2019-2025
12.1.2 Global Erythropoietin (EPO) Revenue Forecast by Regions 2019-2025
12.2 Erythropoietin (EPO) Market Forecast by Product
12.2.1 Global Erythropoietin (EPO) Sales Forecast by Product 2019-2025
12.2.2 Global Erythropoietin (EPO) Revenue Forecast by Product 2019-2025
12.3 Erythropoietin (EPO) Market Forecast by End User
12.4 North America Erythropoietin (EPO) Forecast
12.5 Europe Erythropoietin (EPO) Forecast
12.6 Asia Pacific Erythropoietin (EPO) Forecast
12.7 Central & South America Erythropoietin (EPO) Forecast
12.8 Middle East and Africa Erythropoietin (EPO) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Erythropoietin (EPO) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Erythropoietin (EPO) Product Picture
Table Erythropoietin (EPO) Market Segments
Table Key Manufacturers Erythropoietin (EPO) Covered
Table Global Erythropoietin (EPO) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Erythropoietin (EPO) Sales Market Share by Product 2014-2025
Figure Epoetin-alfa Product Picture
Table Major Manufacturers of Epoetin-alfa
Figure Darbepoetin-alfa Product Picture
Table Major Manufacturers of Darbepoetin-alfa
Figure Epoetin-beta Product Picture
Table Major Manufacturers of Epoetin-beta
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Erythropoietin (EPO) Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Anemia
Figure Kidney Disorders
Figure Other
Figure Erythropoietin (EPO) Report Years Considered
Figure Global Erythropoietin (EPO) Market Size 2014-2025 (Million US$)
Figure Global Erythropoietin (EPO) Sales 2014-2025 (K Units)
Table Global Erythropoietin (EPO) Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Erythropoietin (EPO) Sales by Regions 2014-2019 (K Units)
Table Global Erythropoietin (EPO) Sales Market Share by Regions 2014-2019
Figure Global Erythropoietin (EPO) Sales Market Share by Regions 2014-2019
Figure 2018 Global Erythropoietin (EPO) Sales Market Share by Regions
Table Global Erythropoietin (EPO) Revenue by Regions 2014-2019 (Million US$)
Table Global Erythropoietin (EPO) Revenue Market Share by Regions 2014-2019
Figure Global Erythropoietin (EPO) Revenue Market Share by Regions 2014-2019
Figure 2018 Global Erythropoietin (EPO) Revenue Market Share by Regions
Table Global Erythropoietin (EPO) Sales by Manufacturers (2014-2019) (K Units)
Table Global Erythropoietin (EPO) Sales Share by Manufacturers (2014-2019)
Figure Global Erythropoietin (EPO) Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Erythropoietin (EPO) Revenue by Manufacturers (2014-2019) (Million USD)
Table Erythropoietin (EPO) Revenue Share by Manufacturers (2014-2019)
Figure Erythropoietin (EPO) Value Share by Manufacturers in 2018
Table Key Manufacturers Erythropoietin (EPO) Price (2014-2019) (USD/Unit)
Table Erythropoietin (EPO) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Erythropoietin (EPO) Product Type
Table Date of International Manufacturers Enter into Erythropoietin (EPO) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Erythropoietin (EPO) Sales by Product (2014-2019) (K Units)
Table Global Erythropoietin (EPO) Sales Share by Product (2014-2019)
Figure Global Erythropoietin (EPO) Sales Market Share by Product (2014-2019)
Figure Global Erythropoietin (EPO) Sales Market Share by Product in 2018
Table Global Erythropoietin (EPO) Revenue by Product (2014-2019) (Million US$)
Table Global Erythropoietin (EPO) Revenue Share by Product (2014-2019)
Figure Global Erythropoietin (EPO) Revenue Market Share by Product (2014-2019)
Figure Global Erythropoietin (EPO) Revenue Market Share by Product in 2018
Table Erythropoietin (EPO) Price by Product 2014-2019 (USD/Unit)
Table Global Erythropoietin (EPO) Sales by End User (2014-2019) (K Units)
Table Global Erythropoietin (EPO) Sales Share by End User (2014-2019)
Figure Global Sales Erythropoietin (EPO) Market Share by End User (2014-2019)
Figure Global Sales Erythropoietin (EPO) Market Share by End User in 2018
Figure North America Erythropoietin (EPO) Sales Growth Rate 2014-2019 (K Units)
Figure North America Erythropoietin (EPO) Revenue Growth Rate 2014-2019 (Million US$)
Table North America Erythropoietin (EPO) Sales by Countries (2014-2019) (K Units)
Table North America Erythropoietin (EPO) Sales Market Share by Countries (2014-2019)
Figure 2018 North America Erythropoietin (EPO) Sales Market Share by Countries
Table North America Erythropoietin (EPO) Revenue by Countries (2014-2019) (Million US$)
Table North America Erythropoietin (EPO) Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Erythropoietin (EPO) Revenue Market Share by Countries
Figure United States Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure United States Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Canada Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Table North America Erythropoietin (EPO) Sales by Product (2014-2019) (K Units)
Table North America Erythropoietin (EPO) Sales Market Share by Product (2014-2019)
Figure 2018 North America Erythropoietin (EPO) Market Share by Product
Table North America Erythropoietin (EPO) Sales by End User (2014-2019) (K Units)
Table North America Erythropoietin (EPO) Sales Market Share by End User (2014-2019)
Figure 2018 North America Erythropoietin (EPO) Market Share by End User
Figure Europe Erythropoietin (EPO) Sales Growth Rate 2014-2019 (K Units)
Figure Europe Erythropoietin (EPO) Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Erythropoietin (EPO) Sales by Countries (2014-2019) (K Units)
Table Europe Erythropoietin (EPO) Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Erythropoietin (EPO) Sales Market Share by Countries
Table Europe Erythropoietin (EPO) Revenue by Countries (2014-2019) (Million US$)
Table Europe Erythropoietin (EPO) Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Erythropoietin (EPO) Revenue Market Share by Countries
Figure Germany Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Germany Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure France Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure France Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure UK Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Italy Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Russia Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Erythropoietin (EPO) Sales by Product (2014-2019) (K Units)
Table Europe Erythropoietin (EPO) Sales Market Share by Product (2014-2019)
Figure 2018 Europe Erythropoietin (EPO) Market Share by Product
Table Europe Erythropoietin (EPO) Sales by End User (2014-2019) (K Units)
Table Europe Erythropoietin (EPO) Sales Market Share by End User (2014-2019)
Figure 2018 Europe Erythropoietin (EPO) Market Share by End User
Figure Asia Pacific Erythropoietin (EPO) Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Erythropoietin (EPO) Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Erythropoietin (EPO) Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Erythropoietin (EPO) Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Erythropoietin (EPO) Sales Market Share by Countries
Table Asia Pacific Erythropoietin (EPO) Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Erythropoietin (EPO) Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Erythropoietin (EPO) Revenue Market Share by Countries
Figure China Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure China Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Japan Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Korea Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure India Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure India Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Australia Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Erythropoietin (EPO) Sales by Product (2014-2019) (K Units)
Table Asia Pacific Erythropoietin (EPO) Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Erythropoietin (EPO) Market Share by Product
Table Asia Pacific Erythropoietin (EPO) Sales by End User (2014-2019) (K Units)
Table Asia Pacific Erythropoietin (EPO) Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Erythropoietin (EPO) Market Share by End User
Figure Central & South America Erythropoietin (EPO) Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Erythropoietin (EPO) Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Erythropoietin (EPO) Sales by Countries (2014-2019) (K Units)
Table Central & South America Erythropoietin (EPO) Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Erythropoietin (EPO) Sales Market Share by Countries
Table Central & South America Erythropoietin (EPO) Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Erythropoietin (EPO) Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Erythropoietin (EPO) Revenue Market Share by Countries
Figure Brazil Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Erythropoietin (EPO) Sales by Product (2014-2019) (K Units)
Table Central & South America Erythropoietin (EPO) Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Erythropoietin (EPO) Market Share by Product
Table Central & South America Erythropoietin (EPO) Sales by End User (2014-2019) (K Units)
Table Central & South America Erythropoietin (EPO) Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Erythropoietin (EPO) Market Share by End User
Figure Middle East and Africa Erythropoietin (EPO) Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Erythropoietin (EPO) Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Erythropoietin (EPO) Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Erythropoietin (EPO) Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Erythropoietin (EPO) Sales Market Share by Countries
Table Middle East and Africa Erythropoietin (EPO) Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Erythropoietin (EPO) Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Erythropoietin (EPO) Revenue Market Share by Countries
Figure GCC Countries Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Erythropoietin (EPO) Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Erythropoietin (EPO) Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Erythropoietin (EPO) Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Erythropoietin (EPO) Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Erythropoietin (EPO) Market Share by Product
Table Middle East and Africa Erythropoietin (EPO) Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Erythropoietin (EPO) Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Erythropoietin (EPO) Market Share by End User
Table Amgen Company Details
Table Amgen Erythropoietin (EPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Erythropoietin (EPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Roche Company Details
Table Roche Erythropoietin (EPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Galenica Company Details
Table Galenica Erythropoietin (EPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Galenica Recent Development
Table Emcure Company Details
Table Emcure Erythropoietin (EPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Emcure Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Erythropoietin (EPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table 3SBio Company Details
Table 3SBio Erythropoietin (EPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table 3SBio Recent Development
Table Biocon Company Details
Table Biocon Erythropoietin (EPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocon Recent Development
Table LG Life Sciences Company Details
Table LG Life Sciences Erythropoietin (EPO) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table LG Life Sciences Recent Development
Table Global Erythropoietin (EPO) Sales Forecast by Regions 2019-2025 (K Units)
Table Global Erythropoietin (EPO) Sales Market Share Forecast by Regions 2019-2025
Table Global Erythropoietin (EPO) Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Erythropoietin (EPO) Revenue Market Share Forecast by Regions 2019-2025
Table Global Erythropoietin (EPO) Sales Forecast by Product 2019-2025 (K Units)
Table Global Erythropoietin (EPO) Sales Market Share Forecast by Product 2019-2025
Table Global Erythropoietin (EPO) Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Erythropoietin (EPO) Revenue Market Share Forecast by Product 2019-2025
Table Global Erythropoietin (EPO) Sales Forecast by End User 2019-2025 (K Units)
Table Global Erythropoietin (EPO) Sales Market Share Forecast by End User 2019-2025
Figure North America Erythropoietin (EPO) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Erythropoietin (EPO) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Erythropoietin (EPO) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Erythropoietin (EPO) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Erythropoietin (EPO) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Erythropoietin (EPO) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Erythropoietin (EPO) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Erythropoietin (EPO) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Erythropoietin (EPO) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Erythropoietin (EPO) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Erythropoietin (EPO) Value Chain
Table Erythropoietin (EPO) Customers List
Table Erythropoietin (EPO) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
コリフォリトロピンアルファの世界市場：インサイト・予測 Corifollitropin alfa is a hybrid follicle-stimulating hormone (FSH) molecule, which is used to treat infertility. This molecule when injected results in the development of a high number of metaphase II oocytes in women.The global Corifollitropin Alfa market is valued at xx million US$ in 2018 and wi…- 世界の慢性腎臓病-ミネラル・骨障害（CKD-MBD）市場：専門的調査 Chronic kidney disease mineral bone disorder (MBD) belongs to the bone disease pathology, is characterized by "inadequate bone mineralization" (bonemineralizationdeficiency), which is associated with chronic kidney disease of electrolyte and the direct result of endocrine disorder. The global Chroni…
- 腎臓透析装置の世界市場：インサイト・予測 A dialysis machine tries to mimic some of the functions of a human kidney. One of the primary jobs of a kidney is to remove urea and certain salts from the blood so they can exit the body in urine. In a dialysis machine, blood from the patient runs through tubes made of a semi-porous membrane. Outsi…
- G-CSFバイオシミラーの世界市場：インサイト・予測 Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are…
- 乳酸の世界市場：インサイト・予測 Lactic acid is an organic compound. In its solid state, it is white and water-soluble. In its liquid state, it is colorless. It is produced both naturally and synthetically. With a hydroxyl group adjacent to the carboxyl group, lactic acid is classified as an alpha-hydroxy acid (AHA). In the form of…